[Remission in T-cell prolymphocytic leukemia during the FMC treatment course].
Valiev
T T
TT
Vinogradova
Iu E
IuE
Chernova
N G
NG
Mar'in
D S
DS
Volkova
Ia K
IaK
Petrova
V I
VI
Bulanov
A Iu
AIu
Kalinin
N N
NN
Semenova
E A
EA
Gretsov
E M
EM
Kravchenko
S K
SK
Kremenetskaia
A M
AM
Vorob'ev
A I
AI
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage / Q000627:therapeutic use*; D003520:Cyclophosphamide / Q000008:administration & dosage / Q000627:therapeutic use; D006801:Humans; D015463:Leukemia, Prolymphocytic / Q000175:diagnosis / Q000188:drug therapy*; D015458:Leukemia, T-Cell / Q000175:diagnosis / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D008942:Mitoxantrone / Q000008:administration & dosage / Q000627:therapeutic use; D012074:Remission Induction; D014740:Vidarabine / Q000008:administration & dosage / Q000031:analogs & derivatives / Q000627:therapeutic use
D003520:Cyclophosphamide; D008942:Mitoxantrone; D014740:Vidarabine; C024352:fludarabine